About Bristol-myers squibb
Bristol-Myers Squibb: A Global Biopharmaceutical Company Committed to Innovative Medicines
Bristol-Myers Squibb is a leading global biopharmaceutical company that has been committed to discovering, developing, and delivering innovative medicines to patients with serious diseases for over 130 years. The company's mission is to transform patients' lives through science and innovation.
Headquartered in New York City, Bristol-Myers Squibb operates in more than 60 countries worldwide. The company employs over 30,000 people globally who are dedicated to advancing the science of medicine and improving patient outcomes.
The company's portfolio includes a wide range of innovative medicines across several therapeutic areas such as oncology, cardiovascular disease, immunology, and fibrosis. Bristol-Myers Squibb has a strong pipeline of investigational drugs that are being developed for the treatment of various diseases.
Oncology is one of the key therapeutic areas where Bristol-Myers Squibb has made significant contributions. The company's immuno-oncology portfolio includes Opdivo (nivolumab), which was approved by the U.S. Food and Drug Administration (FDA) in 2014 for the treatment of advanced melanoma. Since then, Opdivo has been approved for several other indications such as non-small cell lung cancer, renal cell carcinoma, classical Hodgkin lymphoma, and others.
Another important drug in Bristol-Myers Squibb's oncology portfolio is Yervoy (ipilimumab), which was approved by the FDA in 2011 for the treatment of metastatic melanoma. Yervoy works by activating T-cells in the immune system to attack cancer cells.
Apart from oncology drugs, Bristol-Myers Squibb also offers innovative treatments for cardiovascular disease such as Eliquis (apixaban), an oral anticoagulant used to prevent blood clots that can cause stroke or systemic embolism in patients with atrial fibrillation or deep vein thrombosis.
In addition to its commitment towards developing innovative medicines for serious diseases, Bristol-Myers Squibb also focuses on sustainability initiatives aimed at reducing its environmental impact while promoting social responsibility within communities where it operates.
The company's sustainability efforts include reducing greenhouse gas emissions from its operations by investing in renewable energy sources such as wind power; implementing water conservation measures; reducing waste generation through recycling programs; promoting diversity and inclusion within its workforce; supporting local communities through philanthropic initiatives; among others.
In conclusion,
Bristol Myers-Squibb is a global biopharmaceutical leader committed towards discovering new ways to improve patient outcomes through innovation-driven research & development activities across multiple therapeutic areas including Oncology & Cardiovascular Disease among others.
With an impressive track record spanning over a century-long history since inception coupled with their unwavering commitment towards sustainable practices aimed at preserving our planet earth while giving back positively into society via philanthropic initiatives - it’s no wonder why they remain one of today’s most respected pharmaceutical companies globally!